Dimerization of protein tyrosine phosphatase σ governs both ligand binding and isoform specificity

Molecular and Cellular Biology

Volumn 27, Issue 5, 2007, Pages 1795-1808

  Lee, Simon ^a   Faux, Clare ^a   Nixon, Jennifer ^a   Alete, Daniel ^a   Chilton, John ^a,b   Hawadle, Muhamed ^a   Stoker, Andrew W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SIGMA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CELL MOTILITY; CONTROLLED STUDY; DIMERIZATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; LIGAND BINDING; LYMPHOCYTE ACTIVATION; MOLECULAR INTERACTION; NERVE GROWTH; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; ANIMALS; AVIAN PROTEINS; CELL LINE; CHICK EMBRYO; CHICKENS; CYSTEINE; DIMERIZATION; GENE DELETION; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE-PHOSPHATASE; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

EID: 33847206745     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00535-06     Document Type: Article

References (66)

1. Aicher, B., M. M. Lerch, T. Muller, J. Schilling, and A. Ullrich. 1997. Cellular redistribution of protein tyrosine phosphatases LAR and PTPσ by inducible proteolytic processing. J. Cell Biol. 138:681-696.
2. Alete, D. E., M. E. Weeks, A. G. Hovanession, M. Hawadle, and A. W. Stoker. 2006. Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma. FEBS J. 273:4668-4681.
3. Alonso, A., J. Sasin, N. Bottini, I. Friedberg, A. Osterman, A. Godzik, T. Hunter, J. Dixon, and T. Mustelin. 2004. Protein tyrosine phosphatases in the human genome. Cell 117:699-711.
4. Aricescu, A. R., W. C. Hon, C. Siebold, W. Lu, P. A. van der Merwe, and E. Y. Jones. 2006. Molecular analysis of receptor protein tyrosine phosphatase mu-mediated cell adhesion. EMBO J. 25:701-712.
5. Aricescu, A. R., I. W. McKinnell, W. Halfter, and A. W. Stoker. 2002. Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol. Cell. Biol. 22:1881-1892.
6. Batt, J., S. Asa, C. Fladd, and D. Rotin. 2002. Pituitary, pancreatic and gut neuroendocrine defects in protein tyrosine phosphatase- sigma-deficient mice. Mol. Endocrinol. 16:155-169.
7. Beltran, P. J., and J. L. Bixby. 2003. Receptor protein tyrosine phosphatases as mediators of cellular adhesion. Front Biosci. 8:D87-D99.
8. Bilwes, A. M., J. Den Hertog, T. Hunter, and J. P. Noel. 1996. Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature 382:555-559.
9. Chang, C., T. W. Yu, C. I. Bargmann, and M. Tessier-Lavigne. 2004. Inhibition of netrin-mediated axon attraction by a receptor protein tyrosine phosphatase. Science 305:103-106.
10. Cheng, H. J., and J. G. Flanagan. 1994. Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases. Cell 79:157-168.
11. Chin, C. N., J. N. Sachs, and D. M. Engelman. 2005. Transmembrane homodimerization of receptor-like protein tyrosine phosphatases. FEBS Lett. 579:3855-3858.
12. Cismasiu, V. B., S. A. Denes, H. Reilander, H. Michel, and S. E. Szedlacsek. 2004. The MAM (Meprin/A5-protein/PTPmu) domain is a homophilic binding site promoting the lateral dimerization of receptor-like protein-tyrosine phosphatase micro. J. Biol. Chem. 279:26922-26931.
13. den Hertog, J., A. Groen, and T. van der Wijk. 2005. Redox regulation of protein-tyrosine phosphatases. Arch. Biochem. Biophys. 434:11-15.
14. den Hertog, J., T. van der Wijk, L. G. Tertoolen, and C. Blanchetot. 2003. Receptor protein-tyrosine phosphatase dimerization. Methods Enzymol. 366:224-240.
15. Elchebly, M., J. Wagner, T. E. Kennedy, C. Lanctot, E. Michaliszyn, A. Itie, J. Drouin, and M. L. Tremblay. 1999. Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma. Nat. Genet. 21:330-333.
16. Ensslen-Craig, S. E., and S. M. Brady-Kalnay. 2004. Receptor protein tyrosine phosphatases regulate neural development and axon guidance. Dev. Biol. 275:12-22.
17. Ferguson, K. M. 2004. Active and inactive conformations of the epidermal growth factor receptor. Biochem. Soc. Trans. 32:742-745.
18. Fernandez-Patron, C., L. Castellanos-Serra, and P. Rodriguez. 1992. Reverse staining of sodium dodecyl sulfate polyacrylamide gels by imidazole-zinc salts: sensitive detection of unmodified proteins. BioTechniques 12:564-573.
19. Fox, A. N., and K. Zinn. 2005. The heparan sulfate proteoglycan syndecan is an in vivo ligand for the Drosophila LAR receptor tyrosine phosphatase. Curr. Biol. 15:1701-1711.
20. Haj, F., I. McKinnell, and A. Stoker. 1999. Retinotectal ligands for the receptor tyrosine phosphatase CRYPα. Mol. Cell Neurosci. 14:225-240.
21. Hibi, M., and T. Hirano. 1998. Signal transduction through cytokine receptors. Int. Rev. Immunol. 17:75-102.
22. Hoylaerts, M. F., T. Manes, and J. L. Millan. 1997. Mammalian alkaline phosphatases are allosteric enzymes. J. Biol. Chem. 272:22781-22787.
23. Jiang, G., J. den Hertog, and T. Hunter. 2000. Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface. Mol. Cell. Biol. 20:5917-5929.
24. Jiang, G., J. den Hertog, J. Su, J. Noel, J. Sap, and T. Hunter. 1999. Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha. Nature 401:606-610.
25. Johnson, K. G., A. P. Tenney, A. Ghose, A. M. Duckworth, M. E. Higashi, K. Parfitt, O. Marcu, T. R. Heslip, J. L. Marsh, T. L. Schwarz, J. G. Flanagan, and D. Van Vactor. 2006. The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development. Neuron 49:517-531.
26. Johnson, K. G., and D. Van Vactor. 2003. Receptor protein tyrosine phosphatases in nervous system development. Physiol. Rev. 83:1-24.
27. Krasnoperov, V., M. A. Bittner, W. Mo, L. Buryanovsky, T. A. Neubert, R. W. Holz, K. Ichtchenko, and A. G. Petrenko. 2002. Protein-tyrosine phosphatase-sigma is a novel member of the functional family of alpha-latrotoxin receptors. J. Biol. Chem. 277:35887-35895.
28. Leahy, D. J., I. Aukhil, and H. P. Erickson. 1996. 2.0 Å crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 84:155-164.
29. Majeti, R., A. M. Bilwes, J. P. Noel, T. Hunter, and A. Weiss. 1998. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279:88-91.
30. Majeti, R., and A. Weiss. 2001. Regulatory mechanisms for receptor protein tyrosine phosphatases. Chem. Rev. 101:2441-2448.
31. Majeti, R., Z. Xu, T. G. Parslow, J. L. Olson, D. I. Daikh, N. Killeen, and A. Weiss. 2000. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103:1059-1070.
32. McLean, J., J. Batt, L. C. Doering, D. Rotin, and J. R. Bain. 2002. Enhanced rate of nerve regeneration and directional errors after sciatic nerve injury in receptor protein tyrosine phosphatase sigma knock-out mice. J. Neurosci. 22:5481-5491.
33. Meathrel, K., T. Adamek, J. Batt, D. Rotin, and L. C. Doering. 2002. Protein tyrosine phosphatase sigma-deficient mice show aberrant cytoarchitecture and structural abnormalities in the central nervous system. J. Neurosci. Res. 70:24-35.
34. Meng, K., A. Rodriguez-Pena, T. Dimitrov, W. Chen, M. Yamin, M. Noda, and T. F. Deuel. 2000. Pleiotrophin signals increased tyrosine phosphorylation of beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc. Natl. Acad. Sci. USA 97:2603-2608.
35. Nam, H. J., F. Poy, H. Saito, and C. A. Frederick. 2005. Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45. J. Exp. Med. 201:441-452.
36. O'Grady, P., T. C. Thai, and H. Saito. 1998. The laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane protein tyrosine phosphatase LAR. J. Cell Biol. 141:1675-1684.
37. Ostman, A., and F. D. Bohmer. 2001. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol. 11:258-266.
38. Ottensmeyer, F. P., D. R. Beniac, R. Z. Luo, and C. C. Yip. 2000. Mechanism of transmembrane signaling: insulin binding and the insulin receptor. Biochemistry 39:12103-12112.
39. Pariser, H., P. Perez-Pinera, L. Ezquerra, G. Herradon, and T. F. Deuel. 2005. Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta. Biochem. Biophys. Res. Commun. 335:232-239.
40. Paul, S., and P. J. Lombroso. 2003. Receptor and nonreceptor protein tyrosine phosphatases in the nervous system. Cell Mol. Life Sci. 60:2465-2482.
41. Pulido, R., N. X. Krueger, C. Serra Pages, H. Saito, and M. Streuli. 1995. Molecular characterization of the human transmembrane protein-tyrosine phosphatase delta. Evidence for tissue-specific expression of alternative human transmembrane protein-tyrosine phosphatase delta isoforms. J. Biol. Chem. 270:6722-6728.
42. Rashid-Doubell, F., I McKinnell, A. R. Aricescu, G. Sajnani, and A. W. Stoker. 2002. Chick PTPσ regulates the targeting of retinal axons within the optic tectum. J. Neurosci. 22:5024-5033.
43. Remy, I., I. A. Wilson, and S. W. Michnick. 1999. Erythropoietin receptor activation by a ligand-induced conformation change. Science 283:990-993.
44. Sajnani, G., A. R. Aricescu, E. Y. Jones, J. Gallagher, D. Alete, and A. Stoker. 2005. PTPσ promotes retinal neurite outgrowth non-cell-autonomously. J. Neurobiol. 65:59-71.
45. Sajnani-Perez, G., J. K. Chilton, A. R. Aricescu, F. Haj, and A. W. Stoker. 2003. Isoform-specific binding of the tyrosine phosphatase PTPσ to a ligand in developing muscle. Mol. Cell Neurosci. 22:37-48.
46. Sapieha, P. S., L. Duplan, N. Uetani, S. Joly, M. L. Tremblay, T. E. Kennedy, and A. Di Polo. 2005. Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS. Mol. Cell Neurosci. 28:625-635.
47. SerraPages, C., H. Saito, and M. Streuli. 1994. Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase. J. Biol. Chem. 269:23632- 23641.
48. Shiang, R., L. M. Thompson, Y. Z. Zhu, D. M. Church, T. J. Fielder, M. Bocian, S. T. Winokur, and J. J. Wasmuth. 1994. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342.
49. Stepanek, L., A. W. Stoker, E. Stoeckli, and J. L. Bixby. 2005. Receptor tyrosine phosphatases guide vertebrate motor axons during development. J. Neurosci. 25:3813-3823.
50. Stoker, A. W. 1994. Isoforms of a novel cell adhesion molecule-like protein tyrosine phosphatase are implicated in neural development. Mech. Dev. 46:201-217.
51. Stoker, A. W. 2005. Protein tyrosine phosphatases and signalling. J. Endocrinol. 185:19-33.
52. Stoker, A. W., B. Gehrig, F. Haj, and B. H. Bay. 1995. Axonal localisation of the CAM-like tyrosine phosphatase CRYP alpha: a signalling molecule of embryonic growth cones. Development 121:1833-1844.
53. Stoker, A. W., B. Gehrig, M. R. Newton, and B. H. Bay. 1995. Comparative localisation of CRYP-alpha, a CAM-like tyrosine phosphatase, and NgCAM in the developing chick visual system. Dev. Brain Res. 90:129-140.
54. Takeda, A., A. Matsuda, R. M. Paul, and N. R. Yaseen. 2004. CD45-associated protein inhibits CD45 dimerization and upregulates its protein tyrosine phosphatase activity. Blood 103:3440-3447.
55. Tertoolen, L. G., C. Blanchetot, G. Jiang, J. Overvoorde, T. W. Gadella, Jr., T. Hunter, and J. den Hertog. 2001. Dimerization of receptor protein-tyrosine phosphatase alpha in living cells. BMC Cell Biol 2:8.
56. Thompson, K. M., N. Uetani, C. Manitt, M. Elchebly, M. L. Tremblay, and T. E. Kennedy. 2003. Receptor protein tyrosine phosphatase sigma inhibits axonal regeneration and the rate of axon extension. Mol. Cell Neurosci. 23:681-692.
57. van der Wijk, T., C. Blanchetot, J. Overvoorde, and J. den Hertog. 2003. Redox-regulated rotational coupling of receptor protein-tyrosine phosphatase alpha dimers. J. Biol. Chem. 278:13968-13974.
58. 2-induced intermolecular disulfide bond formation between receptor protein-tyrosine phosphatases. J. Biol. Chem. 279:44355-44361.
59. Walchli, S., X. Espanel, and R. H. van Huijsduijnen. 2005. Sap-1/PTPRH activity is regulated by reversible dimerization. Biochem. Biophys. Res. Commun. 331:497-502.
60. Wallace, M. J., J. Batt, C. A. Fladd, J. T. Henderson, W. Skarnes, and D. Rotin. 1999. Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPσ. Nat. Genet. 21:334-338.
61. Weiner, D. B., J. Liu, J. A. Cohen, W. V. Williams, and M. I. Greene. 1989. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature 339:230-231.
62. West, M., and V. G. Wilson. 2002. Method for transferring mutations between plasmids. BioTechniques 32:44, 46.
63. Westermark, B., L. Claesson-Welsh, and C. H. Heldin. 1989. Structural and functional aspects of the receptors for platelet-derived growth factor. Prog. Growth Factor Res. 1:253-266.
64. Xu, Z., and A. Weiss. 2002. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3:764-771.
65. Yang, T., W. Yin, V. D. Derevyanny, L. A. Moore, and F. M. Longo. 2005. Identification of an ectodomain within the LAR protein tyrosine phosphatase receptor that binds homophilically and activates signalling pathways promoting neurite outgrowth. Eur. J. Neurosci. 22:2159-2170.
66. Zhang, J. S., and F. M. Longo. 1995. LAR tyrosine phosphatase receptor: alternative splicing is preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing extensive CAG repeats. J. Cell Biol. 128:415-431.